Deborah L. Kociban

Response to trastuzumab, erlotinib, and bevacizumab, alone and in combination, is correlated with the level of human epidermal growth factor receptor-2 expression in human breast cancer cell lines

David R. Emlet, Kathryn Brown, Deborah L. Kociban et al. · Molecular Cancer Therapeutics · 2007 · 54 citations · Full text

Medicine, Oncology, Pharmacology +17

The role of CD4 and CD8 T cells in the graft-versus-leukemia response in Rauscher murine leukemia.

J P Okunewick, Deborah L. Kociban, Laurie Machen et al. · PubMed · 1991 · 30 citations

Life Sciences, Hematology, Immunology +16

Evidence for a possible role of Asialo-GM1-positive cells in the graft-versus-leukemia repression of a murine type-C retroviral leukemia.

J P Okunewick, Deborah L. Kociban, Laurie Machen et al. · PubMed · 1995 · 21 citations

Life Sciences, Cancer Biology, Immunology +5